REDUCE LAP-HF RANDOMIZED TRIAL I: A study to evaluate the Corvia Medical, Inc. IASD System II to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure
A study for patients with heart failure using the IASD System II to reduce elevated left atrial pressure (REDUCE LAP-HF)
Sponsor: Corvia Medical
Enrolling: Male and Female Patients
IRB Number: AAAQ5711
U.S. Govt. ID: NCT02600234
Contact: Robert Sommer: 212-342-0886 /
Additional Study Information: The REDUCE LAP-HF I study is being conducted to evaluate the safety and performance of the InterAtrial Shunt Device (IASD) for patients with elevated left atrial pressure who remain symptomatic despite appropriate medical management. Placed by an interventional cardiologist during a standards catheter-based procedure, the IASD system creates a very small opening between the left and right atria. This opening allows blood to flow from the high pressure left atrium to the low-pressure right atrium. This redistribution of blood to the right side potentially reduces the pressure in the left side and in the lungs. IRB closure in Oct 2017
This study is closed
Robert Sommer, MD
Do You Qualify?
Do you have chronic symptoms of heart failure? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Robert Sommer